Home
|
Contact Us
|
Site Map
|
Search
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Biotherapeutics
Patents
Academic Access
Technology Licensing
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Home
> News
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
08/21/2007
Lexicon Presents Class Of Compounds Modulating TPH1, The Target For Its LX1031 Investigational Drug For Irritable Bowel Syndrome
08/12/2007
Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
07/31/2007
Lexicon Pharmaceuticals Reports 2007 Second Quarter Financial Results
07/30/2007
Lexicon Drug Candidate For Cognitive Disorders Successfully Completes Phase 1 Clinical Trial
07/18/2007
Lexicon to Report Second Quarter 2007 Financial Results on July 31, 2007
07/02/2007
Lexicon Develops Antibodies that Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
06/17/2007
Lexicon Pharmaceuticals Announces Two Agreements to Finance Long-Term Drug Development Strategy
06/07/2007
Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune Deficiency
06/06/2007
Lexicon Pharmaceuticals to Present at the Needham Biotechnology & Medical Technology Conference
05/22/2007
Lexicon Pharmaceuticals to Present at the Bank of America Health Care Conference
«
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
»
Page 4 of 32
back to top
